Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive intravitreal Avastin for prevention of postoperative vitreous haemorrhage after diabetic vitrectomy
ISRCTN79120387Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Oct 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 4, randomised, single-blind trial of bevacizumab in proliferative diabetic retinopathy (PDR), sponsored by Moorfields Eye Hospital. Primary endpoint: Post-operative vitreous haemorrhage. Started Oct 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on ISRCTN79120387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN79120387.